ArticleSAGE open medicine2026
Determinants of viral load non-suppression among adult HIV positive patients on antiretroviral therapy in public health facilities in Ambo town, Ethiopia: A case-control study.
Article in SAGE open medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Viral non-suppression is still a major obstacle to putting an end to the epidemic, although Antiretroviral Therapy (ART) has made HIV a chronic illness that can be managed. Ethiopia has made strides, but there are still regional differences and particular structural obstacles that rural populations must overcome. The purpose of this study was to determine the factors that contribute to adult HIV-positive patients in public health facilities in Ambo town, Ethiopia, not having their viral loads suppressed. Methods: A facility-based unmatched case-control study was carried out from March to May 2023. There were 376 participants in all (131 cases and 245 controls). Trained data collectors conducted secondary reviews of patient charts and electronic records in addition to structured interviews. Data were entered into EpiData version 3.1, then exported to SPSS version 26 for additional statistical analysis. Both bivariate and multivariable logistic regression analyses were performed. In the multiple logistic regression analysis, a p-value of less than 0.05 paired with a 95% confidence interval was utilized to determine statistical significance. Results: According to the multivariable logistic regression analysis, marital status (AOR = 0.232, 95% CI: 0.065-0.830), complexity of the treatment regimen (AOR = 7.333, 95% CI: 3.357-16.017), treatment interruption (AOR = 2.298, 95% CI: 1.146-4.609), follow-up schedule (AOR = 3.721, 95% CI: 2.033-6.812), and adherence (AOR = 16.568, 95% CI: 5.587-49.129) were found to be significantly associated with the viral non-suppression. Conclusion: Viral non-suppression in Ambo is primarily associated with behavioral and treatment-related factors, including poor adherence, high pill burden, and irregular follow-ups. One protective factor observed to have an inverse association is social support, particularly through marriage. A single-tablet regimen and improved adherence support systems, especially for a single group category patients, to meet the 95-95-95 targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.